Find prescribing information about our medicines by clicking on any of the products or Regimen below.
Prescribing Information
Products
ABECMA® (idecabtagene vicleucel)
ABRAXANE® (paclitaxel protein-bound particles)
AUGTYRO® (repotrectinib)
BARACLUDE® (entecavir)
BREYANZI® (lisocabtagene maraleucel)
CAMZYOS® (mavacamten)
COBENFY™ (xanomeline and trospium chloride)
ELIQUIS® (apixaban)
EMPLICITI® (elotuzumab)
EVOTAZ® (atazanavir and cobicistat)
IDHIFA® (enasidenib)
INREBIC® (fedratinib)
ISTODAX® (romidepsin)
KRAZATI® (adagrasib)
NULOJIX® (belatacept)
ONUREG® (azacitadine tablets)
OPDIVO® (nivolumab)
OPDUALAG® (relatlimab and nivolumab)
ORENCIA® (abatacept)
POMALYST® (pomalidomide)
REBLOZYL® (luspatercept-aamt)
REVLIMID® (lenalidomide)
REYATAZ® (atazanavir)
SOTYKTU® (deucravacitinib)
SPRYCEL® (dasatinib)
SUSTIVA® (efavirenz)
THALOMID® (thalidomide)
VIDAZA® (azacitidine)
YERVOY® (ipilimumab)
ZEPOSIA® (ozanimod)
ABECMA, ABRAXANE, AUGTYRO, BARACLUDE, BREYANZI, CAMZYOS, DAKLINZA, ELIQUIS, EMPLICITI, EVOTAZ, IDHIFA, INREBIC, ISTODAX, KRAZATI, NULOJIX, ONUREG, OPDIVO, OPDUALAG, ORENCIA, POMALYST, REBLOZYL, REVLIMID, REYATAZ, SOTYKTU, SPRYCEL, SUSTIVA, THALOMID, VIDAZA, YERVOY, ZEPOSIA are trademarks of Bristol-Myers Squibb Company.
